New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Enliven Therapeutics, Inc.
ELVN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

Next Earning date - 13 May 2025

1B

Biotechnology

Next Earning date - 13 May 2025

20.83USD

Shape0.68 ( 3.37%)
sun-fogPre-market 18.86$arrow-left-down-2.06 (-9.86%)
Market Closed (as of Feb 28, 21:00 EDT)
favorite-chart

Relative Strenght

44
favorite-chart

Volume Buzz

-17%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

31%

Quote Panel

Shape
Updated March 21, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

ELVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7K

ShapeNaN%

2025-Revenue

$2.20

Shape-378%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-09-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.80
vs -2.24

Q2.23

arrow
arrow

N/A

-0.41
vs -1.76

Q3.23

arrow
arrow

N/A

-0.51
vs -0.72

Q4.23

arrow
arrow

N/A

-0.47
vs 1.23

Q1.24

arrow
arrow

N/A

-0.54
vs -0.80

Q2.24

arrow
arrow

N/A

-0.41
vs -0.41

Q3.24

arrow
arrow

N/A

-0.48
vs -0.51

Q4.24

arrow
arrow

N/A

-0.46
vs -0.47

Q1.25

arrow
arrow

N/A

-0.50
vs -0.54

Q2.25

arrow
arrow

N/A

-0.52
vs -0.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

440K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 440K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-4%

-0.04
vs 0.36

Q2.23

arrow
arrow

-6%

-0.06
vs -0.04

Q3.23

arrow
arrow

-8%

-0.08
vs -0.06

Q4.23

arrow
arrow

-8%

-0.08
vs -0.08

Q1.24

arrow
arrow

-7%

-0.07
vs -0.08

Q2.24

arrow
arrow

-7%

-0.07
vs -0.07

Q3.24

arrow
arrow

-8%

-0.08
vs -0.07

Q4.24

arrow
arrow

-7%

-0.07
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

48

48
vs NA

NA

Q2.23

arrow
arrow

63

63
vs 48

31%

Q3.23

arrow
arrow

62

62
vs 63

-2%

Q4.23

arrow
arrow

61

61
vs 62

-2%

Q1.24

arrow
arrow

72

72
vs 61

18%

Q2.24

arrow
arrow

94

94
vs 72

31%

Q3.24

arrow
arrow

102

102
vs 94

9%

Q4.24

arrow
arrow

112

112
vs 102

10%

Earnings Growth

Latest News

ELVN

seekingalpha.com

less than 1 hour ago